Weiwei Yu

782 total citations
42 papers, 624 citations indexed

About

Weiwei Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Weiwei Yu has authored 42 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Weiwei Yu's work include Esophageal Cancer Research and Treatment (8 papers), Gastric Cancer Management and Outcomes (4 papers) and RNA modifications and cancer (4 papers). Weiwei Yu is often cited by papers focused on Esophageal Cancer Research and Treatment (8 papers), Gastric Cancer Management and Outcomes (4 papers) and RNA modifications and cancer (4 papers). Weiwei Yu collaborates with scholars based in China, United States and Thailand. Weiwei Yu's co-authors include Menghong Sun, Jiaqing Xiang, Zhengfei Zhu, Kuaile Zhao, Guangyan Zhangyuan, Weixin Zhao, Wei Qiao, Xiaolong Fu, Beicheng Sun and Xiaochen Wang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Weiwei Yu

38 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Yu China 16 236 233 217 139 127 42 624
Xiaorong Sun China 18 119 0.5× 335 1.4× 105 0.5× 90 0.6× 250 2.0× 73 940
Xiaoyuan Li China 13 172 0.7× 93 0.4× 78 0.4× 67 0.5× 117 0.9× 39 523
Anbok Lee South Korea 13 232 1.0× 165 0.7× 124 0.6× 128 0.9× 192 1.5× 42 694
Leonardo Vincenti Italy 12 284 1.2× 252 1.1× 124 0.6× 156 1.1× 175 1.4× 37 660
Ashwini Esnakula United States 13 158 0.7× 79 0.3× 124 0.6× 114 0.8× 174 1.4× 52 446
Jingjuan Zhu China 12 147 0.6× 194 0.8× 54 0.2× 70 0.5× 204 1.6× 28 483
Naruhiko Mizuta Japan 15 252 1.1× 143 0.6× 187 0.9× 169 1.2× 106 0.8× 44 683
Yonggang He China 16 228 1.0× 119 0.5× 99 0.5× 157 1.1× 134 1.1× 44 503
Frédéric Vallot Belgium 7 251 1.1× 268 1.2× 59 0.3× 109 0.8× 359 2.8× 18 613

Countries citing papers authored by Weiwei Yu

Since Specialization
Citations

This map shows the geographic impact of Weiwei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Yu more than expected).

Fields of papers citing papers by Weiwei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Yu. The network helps show where Weiwei Yu may publish in the future.

Co-authorship network of co-authors of Weiwei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Yu. A scholar is included among the top collaborators of Weiwei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Yu. Weiwei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Weiwei, Kai Jiao, Kaiyan Wang, et al.. (2025). Metabolic support protects mucosa from ferroptosis in radiation-induced mucositis. Nature Communications. 17(1). 520–520.
2.
Yu, Weiwei, et al.. (2023). Prevalence of Primary Drug Resistance Among Newly Diagnosed HIV-1-Infected Individuals in Hunan Province, China. AIDS Research and Human Retroviruses. 39(8). 422–428. 5 indexed citations
3.
Yu, Weiwei, Jiahui Lü, & Cen Wu. (2022). Construction of a novel prognostic signature based on the composition of tumor-infiltrating immune cells in clear cell renal cell carcinoma. Frontiers in Genetics. 13. 1024096–1024096. 2 indexed citations
4.
Yu, Weiwei, et al.. (2021). Synthesis, crystal structure, and biological evaluation of a novel eight-membered dinitration neonicotinoid analogues. Bioorganic & Medicinal Chemistry Letters. 43. 127960–127960. 4 indexed citations
5.
Zhang, Lihua, et al.. (2020). Oncologic outcomes of pre- versus post-operative radiation in Resectable soft tissue sarcoma: a systematic review and meta-analysis. Radiation Oncology. 15(1). 158–158. 12 indexed citations
6.
Yang, Xiaojing, et al.. (2020). Bone Metastases Pattern in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Real‐World Analysis in the SEER Database. BioMed Research International. 2020(1). 2098325–2098325. 9 indexed citations
7.
Yang, Xiaojing, et al.. (2019). A Novel Radiotherapy Approach for Keloids with Intrabeam. BioMed Research International. 2019. 1–7. 12 indexed citations
8.
Zeng, Ya, Wen Yu, Qi Liu, et al.. (2019). Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy. World Journal of Gastrointestinal Oncology. 11(12). 1172–1181. 7 indexed citations
9.
Li, Yida, Weixin Zhao, Jianjiao Ni, et al.. (2019). Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio. Annals of Surgical Oncology. 26(8). 2367–2374. 22 indexed citations
10.
Zhang, Wenjie, Guangyan Zhangyuan, Fei Wang, et al.. (2019). High preoperative serum globulin in hepatocellular carcinoma is a risk factor for poor survival. Journal of Cancer. 10(15). 3494–3500. 18 indexed citations
11.
Wu, Yuanhong, Chao Chen, Ying Luo, et al.. (2019). The effect of esomeprazole vs famotidine on aspirin/clopidogrel dual therapy after percutaneous coronary intervention. Advances in Clinical and Experimental Medicine. 28(11). 1519–1524. 2 indexed citations
12.
Yang, Xiaojing, Yi Sun, Weiwei Yu, & Jie Fu. (2019). Pigmented villonodular synovitis of the temporomandibular joint: case report and the literature review for postoperative radiotherapy. Journal of Radiology Case Reports. 13(8). 31–39. 7 indexed citations
13.
Zhangyuan, Guangyan, Yin Yin, Wenjie Zhang, et al.. (2018). Prognostic Value of Phosphotyrosine Phosphatases in Hepatocellular Carcinoma. Cellular Physiology and Biochemistry. 46(6). 2335–2346. 20 indexed citations
14.
Luo, Ying, et al.. (2018). Effect of Aqueous Extract from Descurainia sophia (L.) Webb ex Prantl on Ventricular Remodeling in Chronic Heart Failure Rats. Evidence-based Complementary and Alternative Medicine. 2018(1). 1904081–1904081. 12 indexed citations
15.
Yu, Weiwei, Xi Yang, Li Chu, et al.. (2018). Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients. Pathology - Research and Practice. 214(7). 1017–1023. 5 indexed citations
16.
Wang, Xiaochen, Ruyi Huang, Guangyan Zhangyuan, et al.. (2017). Prognostic value of marital status on stage at diagnosis in hepatocellular carcinoma. Scientific Reports. 7(1). 41695–41695. 31 indexed citations
17.
Yu, Weiwei, Li Chu, Kuaile Zhao, et al.. (2017). A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinoma. Journal of Cancer. 8(18). 3755–3763. 3 indexed citations
18.
Huang, Ruyi, Xiaochen Wang, Wenjie Zhang, et al.. (2016). Down-Regulation of LncRNA DGCR5 Correlates with Poor Prognosis in Hepatocellular Carcinoma. Cellular Physiology and Biochemistry. 40(3-4). 707–715. 75 indexed citations
19.
Zhu, Zhengfei, Weiwei Yu, Xiaolong Fu, et al.. (2015). Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 95–95. 21 indexed citations
20.
Gao, Shangbang, et al.. (2007). Cerebrosides of baifuzi, a novel potential blocker of calcium‐activated chloride channels in rat pulmonary artery smooth muscle cells. Cell Biology International. 31(9). 908–915. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026